Literature DB >> 21719359

Long-term follow-up after laparoscopic management of endometrial cancer in the obese: a fifteen-year cohort study.

Benoit Rabischong1, Demetrio Larraín, Michel Canis, Guillaume Le Bouëdec, Christophe Pomel, Kris Jardon, Fabrice Kwiatkowski, Nicolas Bourdel, Jean-Louis Achard, Jacques Dauplat, Gerard Mage.   

Abstract

STUDY
OBJECTIVE: To assess the surgical outcomes and long-term results of laparoscopic treatment of endometrial cancer in obese patients, and compare these results with those of nonobese women.
DESIGN: Retrospective cohort study (Canadian Task Force classification II-2).
SETTING: Two referral cancer centers. PATIENTS: Fifty-two obese and 155 nonobese women with clinical stage I endometrial cancer managed by laparoscopy from 1990-2005 in two referral centers.
INTERVENTIONS: Demographic, surgical, perioperative and pathological characteristics of obese women and nonobese women with endometrial cancer treated by laparoscopy were analyzed and then compared. Recurrence-free and overall survival was calculated by use of Kaplan-Meier method.
MEASUREMENTS AND MAIN RESULTS: Median BMI of the study population was 26.2 Kg/m(2). Median BMI among obese patients was 34.2 Kg/m(2). The conversion rate was independent from the BMI of the patient (3.8% vs 4.5%, p = .80). Neither mean operative time (187.5 vs 172 min, p = .11) neither hospital stay (5.2 vs 4.9 days, p = .44) were related with BMI. Lymphadenectomy was considered not feasible in 7 obese (17%) and 8 nonobese (7%) women (p = 0.09). Fewer lymph nodes were retrieved among obese women (8 versus 11, p <.0002). No differences were found between the groups in terms of perioperative complications. Median follow-up was 69 and 71 months for the obese and nonobese, respectively (p = .59). Overall and disease-free 5-year survival rates did not differ between obese and nonobese patients (90.3% and 87.5% versus 88.5% and 89.8%, respectively).
CONCLUSION: Despite some limitations, the laparoscopic approach seems to be particularly useful for obese patients with endometrial cancer, with similar survival and recurrence rates and without any more complications compared to the nonobese population.
Copyright © 2011 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21719359     DOI: 10.1016/j.jmig.2011.05.015

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  5 in total

Review 1.  The Impact of Obesity on Surgical Outcome in Endometrial Cancer Patients: A Systematic Review.

Authors:  Olubunmi Orekoya; Marsha E Samson; Tushar Trivedi; Shraddha Vyas; Susan E Steck
Journal:  J Gynecol Surg       Date:  2016-06-01

2.  The Senhance™ surgical robotic system ("Senhance") for total hysterectomy in obese patients: a pilot study.

Authors:  Salvatore Gueli Alletti; C Rossitto; S Cianci; E Perrone; S Pizzacalla; G Monterossi; G Vizzielli; S Gidaro; G Scambia
Journal:  J Robot Surg       Date:  2017-06-17

Review 3.  Clinical management of obese patients with cancer.

Authors:  Wenjing Tao; Jesper Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2013-07-16       Impact factor: 66.675

4.  Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study.

Authors:  Khaled Gaballa; Islam H Metwally; Basel Refky; Shadi Awny; Mohamed Abdelkhalek; Mohamed Hamdy
Journal:  Indian J Surg Oncol       Date:  2022-01-17

Review 5.  Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis.

Authors:  Angeles Alvarez Secord; Vic Hasselblad; Vivian E Von Gruenigen; Paola A Gehrig; Susan C Modesitt; Victoria Bae-Jump; Laura J Havrilesky
Journal:  Gynecol Oncol       Date:  2015-10-31       Impact factor: 5.482

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.